Auto-generated event page
Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland
The investment will support the upgrade and retrofit of the existing facility and enhance Novo Nordisk’s capacity to manufacture oral GLP-1s outside the US
Score 41
low confidence
1 source posts
Updated Mar 2, 2026, 9:06 AM UTC